Genesee BioMedical
Genesee BioMedical is a Denver-based medical device company founded in 1994 that develops instruments for cardiac surgery, with its flagship TransForm™ Mitral Valve Repair Ring enabling combined surgical and transcatheter mitral valve interventions for lifetime disease management.
- Company typePrivate
- Founded1994
- HeadquartersDenver, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Genesee BioMedical does
Genesee BioMedical, Inc. is a Denver, Colorado-based medical device company founded in 1994 that develops instruments and devices for cardiac surgery. The company operates as a privately held for-profit entity with a workforce of 11-50 employees, focused on the cardiac surgery and interventional cardiology market. Its primary offering is the TransForm™ Mitral Valve Repair Ring, a device whose resting D-shaped geometry transforms toward a circular configuration capable of anchoring transcatheter heart valves.
The core technology centers on the geometric transformation property of the TransForm ring, which enables compatibility between a surgical mitral valve repair implant and balloon-expandable transcatheter heart valves. Bench testing published in the peer-reviewed journal Structural Heart, led by independent researchers under Keith B. Allen, MD, demonstrated proof-of-concept capability for the ring to anchor transcatheter valves in combination. The product is positioned to support lifetime management considerations in mitral valve disease, allowing heart teams to plan sequential or combined surgical and transcatheter interventions for the same patient.
Genesee BioMedical's revenue model, pricing, distribution channels, customer logos, and ownership structure are not disclosed in the available source material. The company appears to be active based on the recent peer-reviewed publication surrounding its TransForm ring, but no financial metrics, funding history, certifications, or partnerships are documented in the input data. The company website (geneseebiomedical.com) was not directly accessible during data collection.
Genesee BioMedical firmographics
Firmographics- Name
- Genesee BioMedical
- Website
- https://geneseebiomedical.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Genesee BioMedical is a Denver-based medical device company founded in 1994 that develops instruments for cardiac surgery, with its flagship TransForm™ Mitral Valve Repair Ring enabling combined surgical and transcatheter mitral valve interventions for lifetime disease management.
- Ownership category
- akta.pro rank
Genesee BioMedical industry classification
Industry- Product category
- Cardiac Surgery Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)
- akta.pro secondary industry
- Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)
Keywords
Where Genesee BioMedical is headquartered
LocationHeadquarters
- HQ city
- Denver
- HQ country
- United States
- HQ region
- North America
Markets served
Genesee BioMedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Genesee BioMedical product offering
Product offeringCore offering
Genesee BioMedical designs, manufactures, and supplies instruments and devices for cardiac surgery. Its flagship product is the TransForm™ Mitral Valve Repair Ring, a surgical implant whose resting D-shaped geometry transforms toward a circular configuration capable of anchoring balloon-expandable transcatheter heart valves, enabling combined surgical-interventional approaches for lifetime management of mitral valve disease.
Product overview
Genesee BioMedical is a medical device company specializing in cardiac surgery products. The company's primary offering is the TransForm™ Mitral Valve Repair Ring, a device designed for mitral valve repair procedures that can anchor transcatheter heart valves when combined with balloon-expandable valves. The TransForm ring transforms from its resting D-shaped geometry toward a circular configuration, demonstrating innovative design for lifetime management of mitral valve disease.
Differentiator
Problem solved
Functional benefit
Products and services
- TransForm™ Mitral Valve Repair Ring
Companies that use Genesee BioMedical
Customer profileSegments1 record
Ideal customer profiles1 record
Genesee BioMedical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Genesee BioMedical partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Genesee BioMedical competitors and assessment
Company assessmentDirect peers
- Edwards Lifesciences: Global leader in structural heart, with the Carpentier-Edwards mitral annuloplasty ring portfolio and the PASCAL transcatheter mitral system — directly comparable in mitral valve repair and the transcatheter space Genesee targets.
- Abbott: Owns MitraClip and a growing structural-heart portfolio addressing mitral repair and replacement; competes for the same heart-team and lifetime-management procedures targeted by Genesee's TransForm ring.
- LivaNova: Cardiac-surgery company offering heart valve repair and replacement products and perfusion instruments — closely aligned with Genesee's cardiac surgery instruments and mitral valve repair focus.
- Artivion: Specializes in cardiac and vascular surgery, including tissue heart valves and surgical repair products; directly comparable niche cardiac-surgery device peer for Genesee BioMedical.
- Corcym: Dedicated heart valve company offering surgical mitral and aortic repair/replacement products including annuloplasty rings; directly competitive in Genesee's mitral repair ring space.
- On-X Life Technologies: Mechanical heart valve manufacturer focused on cardiac surgery valve replacement and repair devices — comparable niche peer in the structural-heart surgical-device space.
Broad incumbents
- Medtronic: Broad cardiovascular incumbent with structural-heart and cardiac-surgery franchises (including Intrepid TMVR). Comparable as a structural-heart competitor but spans far more product categories than Genesee.
- Boston Scientific: Diversified structural-heart player investing in mitral and tricuspid therapies (e.g., transcatheter programs); overlaps thematically with TransForm's transcatheter anchoring capability.
Regional players
- CryoLife (now Artivion subsidiary history): Cardiac surgery tissue preservation and valve company; comparable as a specialty cardiac-surgery device manufacturer targeting similar surgical centers.
Emerging players
- JenaValve Technology: Transcatheter aortic valve company that has explored valve-in-valve and lifetime management concepts; comparable as a small structural-heart player working at the surgical-transcatheter interface relevant to TransForm.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Genesee BioMedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genesee BioMedical leadership team
Management profileNumber of profiles
Profiles3 records
Genesee BioMedical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genesee BioMedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genesee BioMedical
What does Genesee BioMedical do?
Genesee BioMedical designs, manufactures, and supplies instruments and devices for cardiac surgery. Its flagship product is the TransForm™ Mitral Valve Repair Ring, a surgical implant whose resting D-shaped geometry transforms toward a circular configuration capable of anchoring balloon-expandable transcatheter heart valves, enabling combined surgical-interventional approaches for lifetime management of mitral valve disease.
When was Genesee BioMedical founded?
Genesee BioMedical was founded in 1994. It employs 51 to 100 people.
Where is Genesee BioMedical based?
Genesee BioMedical is headquartered in Denver, United States, in the North America region.
Who are Genesee BioMedical's main competitors?
Direct peers on record are Edwards Lifesciences, Abbott, LivaNova, Artivion, Corcym and On-X Life Technologies. Broad incumbents are Medtronic and Boston Scientific. CryoLife (now Artivion subsidiary history) is listed as a regional player. JenaValve Technology is listed as an emerging player.
Does Genesee BioMedical have an API?
No public API is recorded for Genesee BioMedical.
What industry is Genesee BioMedical in?
Genesee BioMedical's product category is Cardiac Surgery Medical Devices. Its primary akta.pro industry code is HLAHAFAB, Structural Heart Valves (TAVR/SAVR) & Valve Repair, with a secondary code of HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts). Its NAICS code is 339113 and its SIC code is 3841.